• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Marketing

medical professionals standing in a hallway at a hospital
Favicon Fierce Pharma

IQVIA taps AI to put overlooked prescribers on marketers’ maps

IQVIA Digital has developed technology to help pharma marketers identify nurse practitioners and physician associates who write prescriptions.
Nick Paul Taylor Jun 15, 2026 11:44am
Astellas
Favicon Fierce Pharma

Inside Astellas CEO's plan to counter Xtandi's patent cliff

Jun 11, 2026 6:00pm
whale jumping out of water
Favicon Fierce Pharma

Orca rides $250M funding wave toward cancer cell therapy launch

Jan 9, 2026 11:19am
change direction new plan alter arrows move reprioritize
Favicon Fierce Pharma

Cybin alters state to become Helus Pharma for Nasdaq trip

Dec 19, 2025 10:30am
New CEO executive boardroom leader
Favicon Fierce Pharma

Amgen obesity marketing head Boulton departs to lead Prolynx

Dec 11, 2025 10:40am
Boerner
Favicon Fierce Pharma

BMS touts commercial execution, reckons with clinical setbacks

Jul 31, 2025 11:10am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings